Female Pattern Baldness Clinical Trial
Official title:
The Efficacy of Visible Red Light for Promoting the Growth of Human Scalp Hair for Both Male and Female - An Open-label Study
A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session applied on every other day for 14 weeks.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00981461 -
Treatment of Androgenetic Alopecia in Females, 9 Beam
|
N/A | |
| Completed |
NCT01451021 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
|
Phase 2 | |
| Completed |
NCT01451138 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)
|
Phase 2 | |
| Completed |
NCT03351322 -
ENERGI-F701 for Female Hair Loss Treatment
|
Phase 2 | |
| Completed |
NCT01451177 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
|
Phase 2 | |
| Completed |
NCT01451125 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
|
Phase 2 | |
| Recruiting |
NCT06333600 -
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05409755 -
Radiofrequency in Female Pattern Hair Loss
|
N/A | |
| Not yet recruiting |
NCT05888922 -
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
|
Phase 3 | |
| Completed |
NCT01669746 -
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)
|
Phase 2 | |
| Completed |
NCT01451099 -
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss
|
Phase 2 | |
| Withdrawn |
NCT04379583 -
HairDx Analytical Validation Study
|
||
| Completed |
NCT01451190 -
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
|
Phase 2 | |
| Completed |
NCT01451047 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)
|
Phase 2 | |
| Not yet recruiting |
NCT05824065 -
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
|
Phase 3 | |
| Not yet recruiting |
NCT02316418 -
Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)
|
N/A | |
| Completed |
NCT01016964 -
Treatment of Androgenetic Alopecia in Females, 12 Beam
|
N/A | |
| Completed |
NCT01451073 -
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)
|
Phase 2 | |
| Completed |
NCT01451151 -
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
|
Phase 2 | |
| Completed |
NCT04898166 -
Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
|